Raynaud's phenomenon and pulmonary arterial hypertension.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Works matching IS 09612033 AND DT 2008 AND VI 17 AND IP 4
Results: 15
1
2
Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 348
- By:
- Publication type:
- Article
3
Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 337, doi. 10.1177/0961203307087403
- By:
- Publication type:
- Article
4
Longitudinal myelitis, aseptic meningitis, and conus medullaris infarction as presenting manifestations of pediatric sysemic lupus erythematosus.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 332, doi. 10.1177/0961203307086638
- By:
- Publication type:
- Article
5
Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 329, doi. 10.1177/0961203307087189
- By:
- Publication type:
- Article
6
Prognostic factors of lupus myelopathy.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 323, doi. 10.1177/0961203307088005
- By:
- Publication type:
- Article
7
Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case--control study within LUMINA, a multiethnic US cohort (LUMINA LVII).
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 314, doi. 10.1177/0961203307087875
- By:
- Publication type:
- Article
8
Defining undifferentiated connective tissue diseases: a challenge for rheumatologists.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 278, doi. 10.1177/0961203307088004
- By:
- Publication type:
- Article
9
Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 300, doi. 10.1177/0961203307087613
- By:
- Publication type:
- Article
10
High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 295, doi. 10.1177/0961203307086930
- By:
- Publication type:
- Article
11
Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 289, doi. 10.1177/0961203307088307
- By:
- Publication type:
- Article
12
Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survival.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 281
- By:
- Publication type:
- Article
13
Rapamycin prevents the development of nephritis in lupus-prone NZB/W F<sub>1</sub> mice.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 305, doi. 10.1177/0961203307088289
- By:
- Publication type:
- Article
14
An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 274, doi. 10.1177/0961203307087188
- By:
- Publication type:
- Article
15
Hydroxychloroquine: the cornerstone of lupus therapy.
- Published in:
- Lupus, 2008, v. 17, n. 4, p. 271, doi. 10.1177/0961203307086643
- By:
- Publication type:
- Article